<DOC>
	<DOCNO>NCT00599638</DOCNO>
	<brief_summary>Pregabalin alpha-2 delta ligand approve treatment neuropathic pain , however , patient respond drug . This study compare efficacy pregabalin administer experimental drug PF-00489791 , patient post-herpetic neuralgia . The efficacy combination compare pregabalin alone .</brief_summary>
	<brief_title>A Study To Compare Pregabalin/PF-00489791 Combination Versus Pregabalin Alone In Post-Herpetic Neuralgia</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia , Postherpetic</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Male female nonchildbearing potential Pain present 3 month heal herpes zoster skin rash VAS score &gt; =40mm screen baseline visit Patients pain condition might impair assessment postherpetic neuralgia Skin condition affect dermatome could alter sensation postherpetic neuralgia History diagnosis DSM IV major depressive disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>